替卡格雷

[CAS号 ] 274693-27-5
[分子式] C23H28F2N6O4S
[分子量] 321.32
[含量] 99％
[外观]白色或无色结晶性粉末
关于替卡格雷
Ticagrelor is a platelet aggregation inhibitor.替卡格雷是血小板聚集抑制剂。 It works by slowing or stopping platelets from sticking to blood vessel walls or injured tissues.它通过减慢或阻止血小板粘附在血管壁或受伤的组织上而起作用。
Ticagrelor is a platelet aggregation inhibitor.Ticagrelor was approved for use in the European Union by the European Commission on December 3, 2010.Ticagrelor was approved by the US Food and Drug Administration on July 20, 2011. Ticagrelor is an antagonist of the P2Y12 receptor.替卡格雷洛是一种血小板聚集抑制剂。替卡格雷洛于XNUMX年XNUMX月XNUMX日获得欧盟委员会批准在欧盟使用。替卡格雷洛于XNUMX年XNUMX月XNUMX日获得美国食品药品监督管理局批准。替卡格雷洛是PXNUMXYXNUMX受体的拮抗剂。 。 Ticagrelor is indicated for the prevention of thrombotic events in people with acute coronary syndrome or myocardial infarction with ST elevation.替卡格雷用于在急性冠脉综合征或ST抬高的心肌梗死患者中预防血栓形成事件。